guaifenesin extended release Mucinex OTC
Selected indexed studies
- Pharmacokinetic Studies in Healthy Subjects for the Development of an Extended-Release Tablet Formulation of Guaifenesin: A 505(b)(2) New Drug Application Approval. (Clin Pharmacol Drug Dev, 2013) [PMID:27121557]
- In brief: Mucinex. (Med Lett Drugs Ther, 2005) [PMID:15711500]
- Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections. (Multidiscip Respir Med, 2017) [PMID:29238574]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- An open-label, randomized, four-treatment crossover study evaluating the effects of salt form, acetaminophen, and food on the pharmacokinetics of phenylephrine. (2018) pubmed
- In brief: Mucinex. (2005) pubmed
- Pharmacokinetic Studies in Healthy Subjects for the Development of an Extended-Release Tablet Formulation of Guaifenesin: A 505(b)(2) New Drug Application Approval. (2013) pubmed
- Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections. (2017) pubmed
- Safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for adjunctive symptom relief of acute respiratory infections. (2009) pubmed